首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1288888

全球合成生物學市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023至2030年預測

Global Synthetic Biology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

據推測，到2030年，全球合成生物學市場的需求將從2022年的11.59億美元達到近80.44億美元，2023-2030年期間的年復合成長率為27.4%。

合成生物學是從工程、生物學、計算機科學和化學發展而來的技術，但這種方法最終被轉向治療學。合成生物學有其各種應用，包括生物基化學品、工業酶、生物燃料、抗體生產、疫苗和合成生物學生命科學研究。生物系統主要是通過塑造核心元件（如遺傳迴路、部分酶和代謝途徑）來推進的。最初，在將較小的設備放入集成系統之前，會對其進行檢查並測試其性能。在細胞、分子和基因水準上的合成生物學的説明下，新藥被製造出來。

市場動態：

全球主要參與者正在投資合成生物學，原因是政府機構專注於氣候變化和生物質。許多行業已經開始將興趣轉向合成生物學，因為它的大規模應用和產生新的基因編輯技術的潛力。這些是影響市場在預測期內增長的一些因素。DNA測序和DNA合成技術以及基因工程產品正在取代傳統藥物。合成生物學中的先進設計和計算系統完全改變了應對遺傳挑戰和新疾病的傳統方法。政府法規和政策，生物安全，生物戰爭和生物安全問題是阻礙市場增長的一些因素。

報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於獲得一個清晰的行業結構圖，並評估全球層面的競爭吸引力。

此外，這些工具還對全球合成生物學市場的每個應用/產品領域進行了全面評估。

區域分析：

這一部分涵蓋了區域分類，強調了北美、歐洲、亞太、拉丁美洲、中東和非洲的合成生物學市場的當前和未來需求。此外，報告還關注了所有重要地區的個別應用部門的需求。

該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。合成生物學市場的主要參與者包括賽默飛世爾科技公司（美國）、默克公司（德國）、安捷倫科技公司（美國）、諾維信公司（丹麥）、Ginkgo Bioworks（美國）、Amyris（美國）、Precigen公司（美國）、GenScript（中國）、Twist Bioscience（美國）、Synthetic Genomics（美國）、Codexis（美國）、Synthego（美國）、Creative Enzymes（美國）、Eurofins Scientific（盧森堡）。這一部分包括對競爭格局的整體看法，其中包括各種戰略發展，如主要的合併和收購、未來能力、夥伴關係、財務概況、合作、新產品的開發、新產品的推出和其他發展。

如果你有任何定製要求，請寫信給我們。我們的研究團隊可以根據您的需要提供定製報告。

區域展望
簡介
北美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 北美地區分部銷售分析
- 北美地區國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲分部銷售分析
- 歐洲國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太其他地區銷售分析
拉美地區銷售分析
- 概況、歷史和預測數據銷售分析
- 拉美地區分部銷售分析
- 拉美地區國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉美其他地區銷售分析
中東和非洲銷售分析
- 概況、歷史和預測數據銷售分析
- 中東和非洲地區分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿聯酋銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第九章：合成生物學公司的競爭格局

合成生物學市場競爭
夥伴關係/合作/協議
合併和收購
新產品發布
其他發展

第十章：公司簡介

公司佔有率分析
市場集中度
Thermo Fisher Scientific Inc. (US)
- 公司概況
- 公司收入
- 產品
- 近期發展
Merck KGaA (Germany)
- 公司概況
- 公司收入
- 產品
- 近期發展
Agilent Technologies (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Novozymes (Denmark)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Ginkgo Bioworks (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Amyris (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Precigen Inc. (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
GenScript (China)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Twist Bioscience (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Synthetic Genomics (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Codexis (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Synthego (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Creative Enzymes (US)
- 公司概覽
- 公司收入
- 產品
- 近期發展
Eurofins Scientific (Luxembourg).
- 公司概覽
- 公司收入
- 產品
- 近期發展情況

注意- 在公司簡介中，財務細節和最近的發展情況取決於可用性，可能不包括私人公司在內。

簡介目錄圖表

Product Code: VMR11211540

The global demand for Synthetic Biology Market is presumed to reach the valuation of nearly USD 80.44 BN by 2030 from USD 11.59 BN in 2022 with a CAGR of 27.4% during the period of 2023-2030.

Synthetic biology is the technology which is developed from engineering, biology, computer science, and chemistry, but the approach was eventually changed towards therapeutics. Synthetic biology has its various applications which includes bio-based chemicals, industrial enzymes, biofuels, antibody production, vaccine and synthetic biology life science research. The biological systems are majorly advanced by molding the core components like genetic circuits, part of enzymes, and metabolic pathways. Initially, smaller devices are examined and their performance is tested before putting them into integrated systems. With the help of synthetic biology on the cellular, molecular and then genetic level, new medicines are been manufactured.

Market Dynamics:

Key players globally are investing in the synthetic biology attribute to the reason that the governmental bodies are focusing towards climate change and biomass. Many industries have initiated to turn their interest in the synthetic biology because of its large scale applications and potential to produce new editing techniques of the gene. These are some of the factors influencing the market to grow during the forecast period. DNA sequencing and DNA synthesis technologies and genetically engineered products are substituting the traditional medicines. Advanced design and computing systems in synthetic biology have completely changed the conventional approach of fighting against the genetic challenges and newer diseases. Government regulations and policies, biosafety, bio-war, and biosecurity issues are some of the factors hampering the market growth.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of synthetic biology.

Market Segmentation:

The entire synthetic biology market has been sub-categorized into application, product, and technology. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Tool

Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids

By Technology

Gene Synthesis
Genome Engineering
Sequencing
Bloinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology

By Application

Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Food & Agriculture
Environmental Applications

Regional Analysis:

This section covers regional segmentation which accentuates on current and future demand for synthetic biology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the synthetic biology market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg). This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . SYNTHETIC BIOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Tool
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY TOOL

5.1 Overview by Tool
5.2 Historical and Forecast Data
5.3 Analysis by Tool
5.4 Oligonucleotides And Synthetic DNA Historic and Forecast Sales by Regions
5.5 Enzymes Historic and Forecast Sales by Regions
5.6 Cloning Technologies Kits Historic and Forecast Sales by Regions
5.7 Synthetic Cells Historic and Forecast Sales by Regions
5.8 Chassis Organisms Historic and Forecast Sales by Regions
5.9 Xeno-nucleic Acids Historic and Forecast Sales by Regions

6 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Gene Synthesis Historic and Forecast Sales by Regions
6.5 Genome Engineering Historic and Forecast Sales by Regions
6.6 Sequencing Historic and Forecast Sales by Regions
6.7 Bloinformatics Historic and Forecast Sales by Regions
6.8 Site-directed Mutagenesis Historic and Forecast Sales by Regions
6.9 Cloning Historic and Forecast Sales by Regions
6.10. Measurement And Modelling Historic and Forecast Sales by Regions
6.11 Microfluidics Historic and Forecast Sales by Regions
6.12 Nanotechnology Historic and Forecast Sales by Regions

7 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Medical Application Historic and Forecast Sales by Regions
7.5 Artificial Tissue And Tissue Regeneration Historic and Forecast Sales by Regions
7.6 Industrial Applications Historic and Forecast Sales by Regions
7.7 Food & Agriculture Historic and Forecast Sales by Regions
7.8 Environmental Applications Historic and Forecast Sales by Regions

8 . GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SYNTHETIC BIOLOGY COMPANIES

9.1. Synthetic Biology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF SYNTHETIC BIOLOGY INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc. (US)
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Merck KGaA (Germany)
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Agilent Technologies (US)
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Novozymes (Denmark)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Ginkgo Bioworks (US)
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Amyris (US)
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Precigen Inc. (US)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. GenScript (China)
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Twist Bioscience (US)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Synthetic Genomics (US)
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Codexis (US)
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Synthego (US)
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Creative Enzymes (US)
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Eurofins Scientific (Luxembourg).
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表